These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11829199)

  • 1. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.
    Raaska K; Raitasuo V; Neuvonen PJ
    Eur J Clin Pharmacol; 2001 Dec; 57(10):705-8. PubMed ID: 11829199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
    Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
    CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole.
    Raaska K; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Apr; 54(2):167-70. PubMed ID: 9626923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.
    Raaska K; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Nov; 56(8):585-9. PubMed ID: 11151749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
    Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
    J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
    Wetzel H; Anghelescu I; Szegedi A; Wiesner J; Weigmann H; Härter S; Hiemke C
    J Clin Psychopharmacol; 1998 Feb; 18(1):2-9. PubMed ID: 9472836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
    Hermida J; Paz E; Tutor JC
    Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.
    Fabrazzo M; Esposito G; Fusco R; Maj M
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):197-200. PubMed ID: 8935816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of clozapine and desmethylclozapine between blood and brain in rats.
    Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
    Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
    Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Another use of silica gel and aqueous eluent for HPLC analysis of clozapine and desmethylclozapine.
    Coudoré F; Nicolay A; Hoareau M; Eschalier A
    J Anal Toxicol; 1999; 23(3):195-9. PubMed ID: 10369329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
    Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
    Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial pneumonia can increase serum concentration of clozapine.
    Raaska K; Raitasuo V; Arstila M; Neuvonen PJ
    Eur J Clin Pharmacol; 2002 Aug; 58(5):321-2. PubMed ID: 12185555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
    Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
    J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.
    Raaska K; Raitasuo V; Laitila J; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):13-8. PubMed ID: 14725610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.
    Rajji TK; Mulsant BH; Davies S; Kalache SM; Tsoutsoulas C; Pollock BG; Remington G
    Am J Psychiatry; 2015 Jun; 172(6):579-85. PubMed ID: 25859763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.
    Nordin C; Almé B; Bondesson U
    Psychopharmacology (Berl); 1995 Nov; 122(2):104-7. PubMed ID: 8848524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.
    Akamine Y; Sugawara-Kikuchi Y; Uno T; Shimizu T; Miura M
    Ann Clin Biochem; 2017 Nov; 54(6):677-685. PubMed ID: 27932669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia.
    Vaquero-Baez M; Díaz-Ruíz A; Tristán-López L; Aviña-Cervantes C; Torner C; Ramírez-Bermúdez J; Montes S; Ríos C
    BMC Psychiatry; 2019 Oct; 19(1):295. PubMed ID: 31597566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.